Table 1. Significance levels (p values) for gene regions with p≤0.005, for either an association with (i) cervical precancer/cancer, (ii) progression to cervical precancer/cancer, (iii) HPV persistence.

	Chromosome	# SNPs	(i)	(ii)	(iii)
Gene			CIN3+ (n=415)	CIN3+ (n=415)	HPV persistence (n=356)
			vs. RC (n=425)†	vs. HPV persistence (n=356)	vs. RC (n=425)
PRDX3 *	10q25-q26	11	0.00015	0.0744	0.16314
RPS19 *	19q13.2	4	0.00045	0.00585	0.45823
DDX1	2p24	13	0.0006	0.69087	0.21284
TELO2	16p13.3	20	0.0009	0.17849	0.65932
C1RL	12p13.31	20	0.00165	0.14029	0.00875
ILDR1	3q13.33	11	0.00285	0.05830	0.88461
THRAP4		6	0.00370	0.80776	0.05615
GDF10	10q11.22	20	0.00400	0.13639	0.04230
GDF2	10q11.22	19	0.00400	0.12639	0.04080
TYMS	18p11.32	20	0.0055	0.30233	0.0015
EVPL	17q25	10	0.02055	0.08985	0.00180
GC	4q12-q13	19	0.0343	0.0004	0.00965
IL2RA	10p15-p14	44	0.24394	0.00115	0.44318
PIK3CA	3q26.3	11	0.91060	0.05145	0.00490

^*FDR for both PRDX3 and RPS19=0.19.

^†RC=random controls.